18 articles for E Zhang
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Structure-based design, SAR analysis and antitumor activity of PI3K/mTOR dual inhibitors from 4-methylpyridopyrimidinone series.

Pfizer
Design and synthesis of a novel pyrrolidinyl pyrido pyrimidinone derivative as a potent inhibitor of PI3Ka and mTOR.

Pfizer
Discovery of a series of 2-(1H-pyrazol-1-yl)pyridines as ALK5 inhibitors with potential utility in the prevention of dermal scarring.

Pfizer
The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex--Part 2.

Pfizer
Recent advances in the exploration of oxazolidinone scaffolds from compound development to antibacterial agents and other bioactivities.

Zhengzhou University
The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex.

Pfizer
Equipotent activity in both enantiomers of a series of ketopiperazine-based renin inhibitors.

Pfizer
Discovery of RO7185876, a Highly Potent γ-Secretase Modulator (GSM) as a Potential Treatment for Alzheimer's Disease.

F. Hoffmann-La Roche
Bound structures of novel P3-P1' beta-strand mimetic inhibitors of thrombin.

Michigan State University
Potent and selective thrombin inhibitors incorporating the constrained arginine mimic l-3-piperidyl(N-guanidino)alanine at P1.

Corvas International
NOTA analogue: A first dithiocarbamate inhibitor of metallo-β-lactamases.

Zhengzhou University
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH

Novartis
Lactams as inhibitors of rock

Bristol-Myers Squibb
Inhibitors of SYK

Hoffmann-La Roche
Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors

Novartis
Substituted cyanoguanidines as oral anti-virals

Abbvie
Heterocyclic derivates

Kalvista Pharmaceuticals
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinase.

Glaxosmithkline